The disease activity parameters ESR, CRP, T28, SW28, PGA, DAS28-CRP, SDAI and CDAI decreased significantly between baseline and week 12 after TAC-based treatment in 33 RA patients for whom pre- and post-treatment samples were available (P < 0.01; Fig. 5A). The gene discussed is CRP; the disease is rheumatoid arthritis.